The Necker–Enfants Malades Hospital is a French teaching hospital in the 15th arrondissement of Paris. It is a hospital of the Assistance Publique – Hôpitaux de Paris group and is affiliated to the University of Paris Descartes.

There are 600 beds in Hôpital Necker-Enfants Malades; Service de neuropédiatrie.

During the past decade, Hôpital Necker-Enfants Malades; Service de neuropédiatrie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hôpital Necker-Enfants Malades; Service de neuropédiatrie" are "Muscular Atrophy, Spinal" (1 trials) and "Spinal Muscular Atrophy" (1 trials). Many other conditions were trialed in "Hôpital Necker-Enfants Malades; Service de neuropédiatrie" in a lesser frequency.

Most popular intervention types in "Hôpital Necker-Enfants Malades; Service de neuropédiatrie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Risdiplam" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Necker-Enfants Malades; Service de neuropédiatrie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Necker-Enfants Malades; Service de neuropédiatrie". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hôpital Necker-Enfants Malades; Service de neuropédiatrie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Necker-Enfants Malades; Service de neuropédiatrie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".